Drug Shortage Report for METHOTREXATE INJECTION USP
Report ID | 228024 |
Drug Identification Number | 02182777 |
Brand name | METHOTREXATE INJECTION USP |
Common or Proper name | METHOTREXATE INJECTION USP |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | METHOTREXATE |
Strength(s) | 25MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL INTRAVENOUS INTRAMUSCULAR INTRA-ARTERIAL |
Packaging size | 1 X 5 VIALS |
ATC code | L01BA |
ATC description | ANTIMETABOLITES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2024-08-07 |
Actual start date | |
Estimated end date | 2024-08-19 |
Actual end date | |
Shortage status | Anticipated shortage |
Updated date | 2024-05-15 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2024-05-15 | French | Compare |
v1 | 2024-05-15 | English | Compare |
Showing 1 to 2 of 2